Competitive Technologies Return on Investment 2010-2016 | CTTC
Current and historical return on investment (ROI) values for Competitive Technologies (CTTC) over the last 10 years.
| Competitive Technologies ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2016-12-31 | $-0.00B | 109.09% | |
| 2016-09-30 | $-0.00B | 57.14% | |
| 2016-06-30 | $-0.00B | 51.61% | |
| 2016-03-31 | $-0.00B | $-0.01B | 40.00% |
| 2015-12-31 | $-0.00B | $-0.01B | 43.24% |
| 2015-09-30 | $-0.00B | $-0.01B | 45.71% |
| 2015-06-30 | $-0.00B | $-0.01B | 50.00% |
| 2015-03-31 | $-0.00B | $-0.01B | 55.17% |
| 2014-12-31 | $-0.00B | $-0.01B | 59.26% |
| 2014-09-30 | $-0.00B | $-0.01B | 84.21% |
| 2014-06-30 | $-0.00B | $-0.01B | 100.00% |
| 2014-03-31 | $-0.00B | $-0.01B | 200.00% |
| 2013-12-31 | $-0.00B | 240.00% | |
| 2013-09-30 | $-0.00B | 133.33% | |
| 2013-06-30 | $-0.00B | 133.33% | |
| 2013-03-31 | $-0.00B | $-0.01B | 106.67% |
| 2012-12-31 | $-0.00B | $-0.00B | 160.00% |
| 2012-09-30 | $-0.01B | $-0.00B | 333.33% |
| 2012-06-30 | $-0.01B | $-0.00B | 666.67% |
| 2012-03-31 | $-0.01B | inf% | |
| 2011-12-31 | $-0.00B | inf% | |
| 2011-09-30 | $-0.00B | inf% | |
| 2011-06-30 | $-0.00B | inf% | |
| 2011-03-31 | $-0.00B | inf% | |
| 2010-10-31 | $-0.00B | inf% | |
| 2010-09-30 | $-0.00B | inf% | |
| 2010-06-30 | $-0.00B | inf% | |
| 2010-04-30 | $-0.00B | inf% | |
| 2010-01-31 | $-0.00B | inf% | |
| 2009-10-31 | $-0.00B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Calmare Therapeutics Incorporated offers patent and technology licensing and commercialization services. The Company identifies and markets technologies in life sciences, including medical testing, diagnostics, pharmaceuticals, biotechnologies, medical devices and other medical applications. It serves product inventors, manufacturers, and distributors. Calmare Therapeutics Incorporated, formerly known as COMPETITIVE TECHNOLOGIES, INC, is based in Westport, CT. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.756B | 26.24 |
| Intuitive Surgical (ISRG) | United States | $136.392B | 85.13 |
| Edwards Lifesciences (EW) | United States | $54.342B | 35.97 |
| DexCom (DXCM) | United States | $52.484B | 90.16 |
| IQVIA Holdings (IQV) | United States | $42.513B | 25.21 |
| IDEXX Laboratories (IDXX) | United States | $41.344B | 49.43 |
| Alcon (ALC) | Switzerland | $40.079B | 29.56 |
| STERIS (STE) | Ireland | $20.158B | 23.86 |
| Waters (WAT) | United States | $19.102B | 27.46 |
| Hologic (HOLX) | United States | $18.152B | 20.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.645B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.255B | 84.68 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $10.792B | 13.33 |
| Teleflex (TFX) | United States | $10.100B | 15.86 |
| Sysmex ADR (SSMXY) | Japan | $10.076B | 31.60 |
| Penumbra (PEN) | United States | $8.416B | 104.04 |
| Masimo (MASI) | United States | $7.298B | 40.93 |
| Globus Medical (GMED) | United States | $6.995B | 22.18 |
| Glaukos (GKOS) | United States | $4.859B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.879B | 24.79 |
| TransMedics (TMDX) | United States | $3.004B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.859B | 18.86 |
| Elekta AB (EKTAY) | Sweden | $2.693B | 18.47 |
| PROCEPT BioRobotics (PRCT) | United States | $2.584B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.578B | 10.58 |
| Inari Medical (NARI) | United States | $2.364B | 407.80 |
| Nihon Kohden (NHNKY) | Japan | $2.359B | 19.95 |
| Tandem Diabetes Care (TNDM) | United States | $2.163B | 0.00 |
| RxSight (RXST) | United States | $2.037B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.835B | 0.00 |
| Veracyte (VCYT) | United States | $1.519B | 0.00 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 15.82 |
| Paragon 28 (FNA) | United States | $0.850B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.849B | 0.00 |
| Artivion (AORT) | United States | $0.843B | 97.43 |
| OrthoPediatrics (KIDS) | United States | $0.740B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.734B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.713B | 0.00 |
| SiBone (SIBN) | United States | $0.615B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.566B | 19.23 |
| IRadimed (IRMD) | United States | $0.523B | 30.36 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.498B | 0.00 |
| Nevro (NVRO) | United States | $0.482B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.399B | 0.00 |
| CVRx (CVRX) | United States | $0.372B | 0.00 |
| NeuroPace (NPCE) | United States | $0.355B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 11.82 |
| AxoGen (AXGN) | United States | $0.315B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.288B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.281B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.226B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.194B | 10.47 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.157B | 0.00 |
| Neuronetics (STIM) | United States | $0.129B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.122B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.095B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 112.67 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| InspireMD (NSPR) | Israel | $0.054B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.046B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.024B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |